rss
Sex Transm Infect 2004;80:329
  • Brief Encounters

Brief Encounters

  1. Helen Ward,
  2. Rob Miller, Editors

      RAPID PUBLICATION

      In this issue we have taken the unusual step of “fast tracking” two papers (see p 330 and p 335), which will have a time from acceptance to publication of under two months as opposed to our average of eight months. We hope that the reasons are obvious. One aims to influence management and thereby improve the treatment of gonorrhoea, and the other provides an up to date picture of the chlamydia screening programme in England, a subject of great interest to the specialty, to patients, and to the media. In future, if you think you have something worthy of rapid publication please include a justification for this in your letter at the time of submission.
 See p 330 and 335

      SORTING OUT GONORRHOEA TREATMENT

      The recommended first line treatment for gonorrhoea recently changed from ciprofloxacin to a cephalosporin, in line with results from surveillance data on antibiotic resistance.1 But which cephalosporin? Ison and …

      [Full text of this article]

      This Article

      1. Extract
      2. Full text
      3. PDF

      Responses

      1. Submit a response
      2. No responses published

      Register for free content

      The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

      Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.